{"nct_id":"NCT03249792","title":"Study of MK-2118 Administered as Intratumoral Injection as Monotherapy and in Combination With Pembrolizumab (MK-3475) or by Subcutaneous Injection in Combination With Pembrolizumab in the Treatment of Adults With Advanced/Metastatic Solid Tumors or Lymphomas (MK-2118-001)","status":"TERMINATED","status_verified_date":"2025-07","start_date":"2017-09-20","start_date_type":"ACTUAL","primary_completion_date":"2023-02-22","primary_completion_date_type":"ACTUAL","completion_date":"2023-02-22","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRK"]}